These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23619263)

  • 1. IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis.
    Ronsoni MF; Lazzarotto C; Fayad L; Silva MC; Nogueira CL; Bazzo ML; Narciso-Schiavon JL; Dantas-Corrêa EB; Schiavon Lde L
    Ann Hepatol; 2013; 12(3):456-63. PubMed ID: 23619263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis.
    Colakoğlu O; Taşkiran B; Colakoğlu G; Kizildağ S; Ari Ozcan F; Unsal B
    Turk J Gastroenterol; 2007 Dec; 18(4):245-9. PubMed ID: 18080921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulinlike growth factor-1 and its binding protein-3 levels in children with cirrhosis waiting for a liver transplant.
    Dehghani SM; Karamifar H; Hamzavi SS; Haghighat M; Malek-Hosseini SA
    Exp Clin Transplant; 2012 Jun; 10(3):252-7. PubMed ID: 22631062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
    Wu YL; Ye J; Zhang S; Zhong J; Xi RP
    World J Gastroenterol; 2004 Sep; 10(18):2740-3. PubMed ID: 15309731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor I correlates with MELD and returns to normal level after liver transplantation.
    Castro GR; Coelho JC; Parolin MB; Matias JE; de Freitas AC
    Ann Transplant; 2013 Feb; 18():57-62. PubMed ID: 23792502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease.
    Chen CY; Tsai WL; Lin PJ; Shiesh SC
    Clin Chem Lab Med; 2011 Nov; 49(11):1817-21. PubMed ID: 21851314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis.
    Assy N; Hochberg Z; Amit T; Shen-Orr Z; Enat R; Baruch Y
    J Hepatol; 1997 Nov; 27(5):796-802. PubMed ID: 9382965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin-like growth factor binding protein 3 ternary complex is reduced in cirrhosis.
    Ottesen LH; Bendtsen F; Flyvbjerg A
    Liver; 2001 Oct; 21(5):350-6. PubMed ID: 11589772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S; Juul A; Becker U; Flyvbjerg A; Skakkebaek NE; Henriksen JH
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects.
    Jørgensen JO; Vahl N; Hansen TB; Skjaerbaek C; Fisker S; Orskov H; Hagen C; Christiansen JS
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):479-86. PubMed ID: 9640415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein-3: a novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis.
    Shaarawy M; Fikry MA; Massoud BA; Lotfy S
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3316-9. PubMed ID: 9745447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.
    Johansson P; Åberg D; Johansson JO; Mattsson N; Hansson O; Ahrén B; Isgaard J; Åberg ND; Blennow K; Zetterberg H; Wallin A; Svensson J
    Psychoneuroendocrinology; 2013 Sep; 38(9):1729-37. PubMed ID: 23473966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis.
    Assy N; Hochberg Z; Enat R; Baruch Y
    Dig Dis Sci; 1998 Jun; 43(6):1317-21. PubMed ID: 9635625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acid-labile subunit of the ternary insulin-like growth factor complex in cirrhosis: relation to liver dysfunction.
    Møller S; Juul A; Becker U; Henriksen JH
    J Hepatol; 2000 Mar; 32(3):441-6. PubMed ID: 10735614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
    Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
    Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study.
    Zou D; Qi X; Zhu C; Ning Z; Hou F; Zhao J; Peng Y; Li J; Deng H; Guo X
    Turk J Gastroenterol; 2016 Mar; 27(2):180-6. PubMed ID: 27015623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.